Apellis’ Research Collaboration With Beam Therapeutics

Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals on the deal.Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. (Nasdaq: BEAM), announced that they had…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now